FDA Approves First Canine Cancer Therapy

Dog with bone cancer of the right humeral head

Pfizer Animal Health Receives Approval for PALLADIATM

MONTREAL--(BUSINESS WIRE)--Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved the first canine cancer therapy in the U.S. – PALLADIATM (toceranib phosphate) – which was developed by Pfizer to treat mast cell tumors in dogs. Pfizer made the announcement to veterinarians attending the 2009 American College of Veterinary Internal Medicine (ACVIM) Forum and Canadian Veterinary Medical Association Convention.

“Pfizer Animal Health is proud to bring the first canine cancer therapy approved by the FDA to U.S. specialists, their patients and caregivers,” said George Fennell, vice president, Companion Animal Division, Pfizer Animal Health. “In the weeks and months ahead, Pfizer will introduce PALLADIA to boarded specialists to expand the body of clinical experience with this new therapy. The experience gained during this time will enable us to support veterinarians more effectively when we make the product available for purchase in early 2010,” Fennell said.

Pet caregivers should continue to consult with their local veterinarians about options for their dogs with cancer, who may then refer appropriate cases to specialists for treatment with PALLADIA.

full article

Comments

[Anne Good]

I'm not liking how Big Pharma can now easily manage the "health care" of our pets so I'll continue looking into more effective cancer treatment alternatives.

[Suzanne]

If you've watched a lovely greyhound courageously battle bone cancer, (not uncommon & some think caused by steroids used at tracks) you'd thank any kind of help and breakthroughs in cancer treatment that doesn't involve cutting off a leg. How wonderful that a company such as this is interested in pets.